GlassScriptPhysician profile
Stanley L Tao
NPI 1811934805
$12,525.27
in general payments reported to CMS, 2019-2025
19 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,437 · 2020: $99.03 · 2021: $200 · 2022: $1,763 · 2023: $1,600 · 2024: $1,341 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,026.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,122.80 | 2019-2021 | |
| Alimera Sciences, INC. | $2,685.30 | 2019-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $1,907.59 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $440.58 | 2023-2025 | Ozurdex |
| Regeneron Pharmaceuticals, INC. | $371.66 | 2022-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $283.12 | 2022-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $220.02 | 2023-2025 | Izervay |
| Alcon Vision LLC | $110.76 | 2024-2025 | Constellation, Unity, Tryptyr |
| Ani Pharmaceuticals, INC. | $65.71 | 2024-2025 | Yutiq, Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $50.56 | 2019-2020 | |
| Thea Pharma INC. | $49.81 | 2024-2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $37.06 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $36.97 | 2023-2024 | Xipere, Lotemax Sm, Zylet |
| Sun Pharmaceutical Industries INC. | $33.79 | 2019 | |
| Shire North American Group INC | $31.20 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $26.66 | 2024 | Byooviz |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $17.71 | 2023 | Tepezza |
| Dompe US, INC. | $14.57 | 2023 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Tao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.